SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for COMPUGEN LTD (CGEN) (CIK 0001119774) (CGEN) — Aug 7, 2019

COMPUGEN LTD (CGEN) (CIK 0001119774)
Date: Aug. 7, 2019 · CIK: 0001119774 · Accession: 0000000000-19-012150

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-233001

Date
August 7, 2019
Author
Ari Krashin
Form
UPLOAD
Company
COMPUGEN LTD (CGEN) (CIK 0001119774)

Letter

August 7, 2019 Ari Krashin Chief Financial and Operating Officer Compugen Ltd. 26 Harokmim Street Holon 5885849, Israel Re:Compugen Ltd. Registration Statement on Form F-3 Filed August 5, 2019 File No. 333-233001 Dear Mr. Krashin: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Irene Paik at 202-551-6553 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Daniel I. Goldberg - Cooley LLP

Show Raw Text
August 7, 2019
Ari Krashin
Chief Financial and Operating Officer
Compugen Ltd.
26 Harokmim Street
Holon 5885849, Israel
Re:Compugen Ltd.
Registration Statement on Form F-3
Filed August 5, 2019
File No. 333-233001
Dear Mr. Krashin:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Irene Paik at 202-551-6553 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc:       Daniel I. Goldberg - Cooley LLP